The St. Louis County on Tuesday will vote on legislation that would appropriate a grant from the state’s STOP Violence Against Women Program.
The legislation which is up for final passage would authorize the county executive to accept a grant of up to $261,020 from the Missouri Department of Public Safety as part of the STOP Violence Against Women Program.
According to Missouri’s Department of Public Safety’s website, the STOP Program encourages the development and strengthening of effective law enforcement and prosecution strategies to address violent crimes against women and the development and strengthening of victim services in cases involving violent crimes against women.
At the March 6 County Council meeting there was similar legislation that was introduced that would accept a grant for $46,195.61.
The appropriated money would be used to retain one full-time case worker and one clinical social worker who will provide or coordinate direct care for women and children Kathy J. Weinman Shelter, for a period of Jan. 1, 2018 to Dec. 31.
The Kathy J. Weinman Shelter, is a shelter located in St. Louis County that features 39 beds and a domestic violence program to help and assist abused women and their children.
Also on Tuesday, the County Council will vote on a bill in its perfection stage that would allow the county to enter into a contract with the University of Missouri to carry out grant activities related to the Prescription Drug Monitoring Program (PDMP).
The legislation which Stenger is recommending comes from Dr. Faisal Khan, the director of the St. Louis County Department of Health, which would allow the county to enter into a contract with the Board of Curators at Mizzou.
The university will assist the St. Louis County Department of Public Health by conducting research and evaluation into data used to address the heroin and opioid use.
The county’s Prescription Drug Monitoring Program which launched in April, seeks to improve opioid prescribing by providing critical information regarding a patient’s controlled substance history and informing clinical practices by identifying patients at high-risk.